The pharmacy retail market is valued at INR 216 bn in 2009 and estimated to reach INR 432 bn in 2011. The market is fragmented and dominated by the unorganized sector.
The report provides a snapshot of the pharmacy retail market. Market overview gives a quick picture of the market with estimated market size, growth rate and revenue split between the organized and unorganized sector. An analysis of drivers reveals that growth in pharmaceuticals sector, increase in healthcare spending, changing disease profile, consumer attitudes, attractive margins and growth in OTC segment is driving growth in this sector. The key challenges identified include fragmented nature of Industry, lengthy supply chain, counterfeit drugs and FDI Regulations.
The report identifies the current market trends including loyalty schemes, value added services, tie-ups with retail firms, rural expansion, entry of Government in pharmacy retailing, entry of private labels, organized retailers starting pharmacy chains. The competitive landscape profiles the major players in this sector including the business description, number of stores and expansion plans for each player. The report also provides details of the key developments in this sector.
India pharmacy retail market report -2020 |India Pharmacy Retail MarketKen Research Pvt ltd.
India Pharmacy Retail Market Outlook to 2020 – Growth Driven by Surge in OTC Drugs Sales and Expansion of Online Pharmacies” provides a comprehensive analysis of the various aspects such as market size of the India Pharmacy Retail and Online Pharmacy Retail Market. The report also covers the market segmentation on the basis of organized & unorganized pharmacies, prescribed drugs, OTC drugs & private label products, category of drugs and generic & patented drugs. The report shares the company profile and competitive landscape for major players in the organized pharmacy sector and online pharmacy market.
Pharmacy retail market in India is driven by growth in the pharmaceutical sector, registered revenues of INR ~ billion in FY’2015. With the advent of online pharmacy retailers in the market, the industry is likely to witness a surge in the coming future. The retail pharmacy in the India has escalated at a CAGR of 19.4% from INR ~ billion in FY’2010 to INR ~ billion in FY’2015. The surge in growth is chiefly guided by the escalation in urbanization, increase in household expenditures, increasing smartphone users, need for convenience and rising literacy rate in the country coupled with growing medical awareness.
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Market research for Indian Pharmaceutical Market switching over from prescribed to OTC products. Scope of Indian Pharmaceutical OTC market, opportunities and challenges.
This was the PowerPoint presentation done in the 4th year of Pharm.D for Clinical Pharmacy subject by our team. The team composed of Agathiyan, Anandharaj, Atchayaa and Chathreian.
It represents our Indian healthcare, pharmaceutical market and e-pharmacy growth (comparison with the retail pharmacy) in the past and future perspective.
India pharmacy retail market report -2020 |India Pharmacy Retail MarketKen Research Pvt ltd.
India Pharmacy Retail Market Outlook to 2020 – Growth Driven by Surge in OTC Drugs Sales and Expansion of Online Pharmacies” provides a comprehensive analysis of the various aspects such as market size of the India Pharmacy Retail and Online Pharmacy Retail Market. The report also covers the market segmentation on the basis of organized & unorganized pharmacies, prescribed drugs, OTC drugs & private label products, category of drugs and generic & patented drugs. The report shares the company profile and competitive landscape for major players in the organized pharmacy sector and online pharmacy market.
Pharmacy retail market in India is driven by growth in the pharmaceutical sector, registered revenues of INR ~ billion in FY’2015. With the advent of online pharmacy retailers in the market, the industry is likely to witness a surge in the coming future. The retail pharmacy in the India has escalated at a CAGR of 19.4% from INR ~ billion in FY’2010 to INR ~ billion in FY’2015. The surge in growth is chiefly guided by the escalation in urbanization, increase in household expenditures, increasing smartphone users, need for convenience and rising literacy rate in the country coupled with growing medical awareness.
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Market research for Indian Pharmaceutical Market switching over from prescribed to OTC products. Scope of Indian Pharmaceutical OTC market, opportunities and challenges.
This was the PowerPoint presentation done in the 4th year of Pharm.D for Clinical Pharmacy subject by our team. The team composed of Agathiyan, Anandharaj, Atchayaa and Chathreian.
It represents our Indian healthcare, pharmaceutical market and e-pharmacy growth (comparison with the retail pharmacy) in the past and future perspective.
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”Dharmik Bhatt
Main Objective
To find the Strength, weakness, Opportunities and threat of the company and all new pharmaceutical companies.
To find out the perception and expectation of doctors and retailers towards the new pharmaceutical company.
Sub Objectives
To find out the big player of the market (Tough Competitor).
To find the way for new pharmaceutical company from tough competition.
To create strategy for company with the help of research detail.
To analyze Vadodara market for company.
To create good communication bridge between new company to doctors and retailers, that full feel all require expectation of both.
UBC Phar400 Business of Retail Pharmacy-13Sept2013Gerry Spitzner
Presented to 4th year Pharmacy students at UBC Pharmaceutical Sciences in the Phar400 Pharmacy Business Management course.
In this first presentation of the semester we take a high level look at the business of Pharmacy in Canada and British Columbia.
Learning objectives:
>Pharmacy business in Canada and BC
>Retail Pharmacy types and main differences
>Pharmaceutical Logistics and Supply Chain
>4 key controllable moving parts of retail Pharmacy
>Future Developments, Trends, Issues & Opportunities
As part of the curriculum students are required to work in teams to create a new sustainable professional clinical service supported by a business plan. At the end of the semester the teams present in a "pitch" to classmates and a panel of judges. Winners are determined by their peers.
Introduction to Consumer Behaviour; Consumer Behaviour
and Marketing Strategy; Consumer Involvement – Levels
of involvement, and Decision Making
Consumer Decision Process – Stages in Decision Process,
Information Search Process; Evaluative Criteria and
Decision Rules, Consumer Motivation – Types of Consumer
Needs, Ways of Motivating Consumers. Information
Processing and Consumer Perception.
Consumer Attitudes and Attitude Change; Influence of
Personality and Self Concept on Buying Behaviour,
Psychographics and Lifestyles, Impuse Buying.
Diffusion of Innovation and Opinion Leadership, Family
Decision Making, Influence of Reference Group
Industrial Buying Behaviour– Process and factors, Models
of Consumer Behaviour – Harward Seth, Nicosia, E& D,
Economic Model; Introduction to Consumer Behaviour
Audit; Consumer Behaviour Studies in India
10 ten best, average and worst Points of Pharmaceutical marketingAnjum Iqbal
10 ten best, average and worst Points of Pharmaceutical marketing.
Basically this presentation is related to the pharmaceutical marketing. . . that which type of strategies become best , worst and average for the pharmaceutical marketing.
this is just powerpoint of the report on a pharma company this was to present in the class and for the ease to understand the research of principle of marketing in institute of business management IoBM
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”Dharmik Bhatt
Main Objective
To find the Strength, weakness, Opportunities and threat of the company and all new pharmaceutical companies.
To find out the perception and expectation of doctors and retailers towards the new pharmaceutical company.
Sub Objectives
To find out the big player of the market (Tough Competitor).
To find the way for new pharmaceutical company from tough competition.
To create strategy for company with the help of research detail.
To analyze Vadodara market for company.
To create good communication bridge between new company to doctors and retailers, that full feel all require expectation of both.
UBC Phar400 Business of Retail Pharmacy-13Sept2013Gerry Spitzner
Presented to 4th year Pharmacy students at UBC Pharmaceutical Sciences in the Phar400 Pharmacy Business Management course.
In this first presentation of the semester we take a high level look at the business of Pharmacy in Canada and British Columbia.
Learning objectives:
>Pharmacy business in Canada and BC
>Retail Pharmacy types and main differences
>Pharmaceutical Logistics and Supply Chain
>4 key controllable moving parts of retail Pharmacy
>Future Developments, Trends, Issues & Opportunities
As part of the curriculum students are required to work in teams to create a new sustainable professional clinical service supported by a business plan. At the end of the semester the teams present in a "pitch" to classmates and a panel of judges. Winners are determined by their peers.
Introduction to Consumer Behaviour; Consumer Behaviour
and Marketing Strategy; Consumer Involvement – Levels
of involvement, and Decision Making
Consumer Decision Process – Stages in Decision Process,
Information Search Process; Evaluative Criteria and
Decision Rules, Consumer Motivation – Types of Consumer
Needs, Ways of Motivating Consumers. Information
Processing and Consumer Perception.
Consumer Attitudes and Attitude Change; Influence of
Personality and Self Concept on Buying Behaviour,
Psychographics and Lifestyles, Impuse Buying.
Diffusion of Innovation and Opinion Leadership, Family
Decision Making, Influence of Reference Group
Industrial Buying Behaviour– Process and factors, Models
of Consumer Behaviour – Harward Seth, Nicosia, E& D,
Economic Model; Introduction to Consumer Behaviour
Audit; Consumer Behaviour Studies in India
10 ten best, average and worst Points of Pharmaceutical marketingAnjum Iqbal
10 ten best, average and worst Points of Pharmaceutical marketing.
Basically this presentation is related to the pharmaceutical marketing. . . that which type of strategies become best , worst and average for the pharmaceutical marketing.
this is just powerpoint of the report on a pharma company this was to present in the class and for the ease to understand the research of principle of marketing in institute of business management IoBM
1) Layout and Physical Facilities For Medical Store
• Designing a Drug Store
• Location and Layout of the Hospital Pharmacy
• Layout
• Flow charts for Materials and Members
General Flow Chart Out Patients
General Flow Chart In Patients
General Flow Chart for Materials
• Selection of Site Space, Layout & Design For Community Pharmacy
• Plan an Ideal Retail and Whole sale Store
• Legal Requirements
General Licenses
Restricted Licenses
• Physical Facility
Personal and Floor space Requirement including Equipments
2) Staff
• Selection Of Staff
• Compensation
3) Receipt of drugs
• What is a Drug?
• Requisition, Supply and Receipt of Drugs
Drug request
Completing Stores Requisition/ Delivery (issue) Form
• Supply of Drugs from Medical Stores
Store Requisition / Delivery (issue) Form
Receipt of drugs at Dispensary
4) Disposal of Expired Drugs
5) Drug Safety
6) Unit dose dispensing
• What is UDD
• ADVANTAGES
7) Guidelines To Minimize Pilerage of Drugs
8) Hathi Committee Recommendation For Hospital Pharmacy
Rural market in India: A special reference to Pharma Marketing: Dr D K MehtaDr. D K Mehta
Strategy to sustain Growth in Pharma Marketing, Innovation in Pharmaceutical Marketing, Brand Building through alternative route in Pharma marketing, India, Asia, ASEAN, CIS, MENA and LATAM strategy, Healthcare Marketing, India Growth Stratefy
Market Research Report : Pharmacy Retail Market in India 2012Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
The Pharmacy Retail Market inIndiais a considerably big market already but has tremendous scope to grow further. Retail pharmacy outlets happens to be the most dominant distribution channel that is responsible for satisfying customer needs of pharmaceutical and allied products directly.
The report begins with the introduction section that deals with the growing significance and work scope of pharmacy retailers followed by the various formats of stores prevalent in the country and the distribution channel from pharmacy manufacturer to the retailer.
The market overview section provides an insight into the current and forecasted market size of the pharmacy retail market till 2016. The significance of retail outlets as the most popular pharmacy sales source is conceived from the market trend figures.
The report is then provided with the driving factors that are encouraging the pharmacy retail market among which the growing pharmaceutical market finds a prominent position. Increased healthcare spending, changing disease profile, growing OTC segment, consumer’s attitude towards their disease and illness and lucrative profit margins evolve as the possible reasons for the industry to prosper. A detailed analysis has been made of the drivers. The key challenges of the industry have also been analysed of which fragmentation of the market into organized and unorganized sections is a primary reason. Others include long distribution and supply chain that involves too many middlemen in the business and the existence of counterfeit drugs.
Market Research Report : OTC Drug Market in India 2011Netscribes, Inc.
For the complete report, get in touch with us at : info@netscribes.com
Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position within the next five years. Since Indian patients have a huge tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign and domestic players. Rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, increasing focus on brand building, booming retail growth and changing demographics is helping the market to grow. The Indian Government, on its part has taken initiatives to reduce drug prices, has made certain reforms in the tax structure and has undertaken various other initiatives to promote the OTC market. The market is expected to exhibit steady growth over the next few years.
The report begins with the introduction section which offers a brief insight into the major over-the-counter segments. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. The top ten OTC brands in both the Indian and the global market, along with the sales figures have been provided. The report also provides individual market sizes for the different segments of the OTC market.
An analysis of the drivers explains the factors for growth of the industry including rising consumer confidence in OTC products, increasing number of shifts from prescription to OTC drugs, booming retail growth, increasing focus on brand building, changing demographics and lower price control. The key challenges include low penetration in rural areas, preference of home remedies to OTC products, high competition and time consuming clinical trial procedures
The government initiatives section gives analyses the efforts to reduce drug prices, changes in the customs duty structure and the various other initiatives undertaken by the Government.
A brief overview of the drug market value chain and drug regulations is presented in the next section. It analyses the pharmaceutical value chain, and focuses on the different stages of clinical trial that a drug must pass through. A snapshot of different regulatory frameworks existing in the Indian pharma industry has been shown.
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.
ToC
Page 1: Executive summary
Introduction
Page 2: Major OTC segments
Market Overview
Page 3: Global OTC Drug Market – Overview, Size, & Growth (Value: 2009-15e), Distribution figures (2009)
Page 4: Top 10 global OTC brands – Names & sales figures (2009)
Page 5: Indian OTC Drug Market- Overview, Size &
The healthcare industry in India is showing great progress. There has been considerable increase in spending on healthcare backed by the growing purchasing power of individuals. Moreover, with a lot of importance being given to preventive medication, the nutraceuticals market in India is set to flourish. It is one of the booming markets in India. Predominantly vitamins and minerals derived from oral pills were used for curing certain diseases and ailments. People today are becoming more prone to consume immunity enhancing food supplements and wellness related products. This is promoting the growth of the industry with players diversifying into production of various new varieties of products. Further assistance from the government and increasing demand from consumers will fuel growth in this market.
The report begins with an introduction to the Indian nutraceuticals market and its classification on the basis of the ingredients and benefits incurred from them. This is followed by the market overview section which provides the market size and growth as well as the market share of the various segments in the market, namely, functional foods, dietary supplements and functional beverages. A detailed description of each segment in the market along with the dominant products in the particular category has also been provided. Focusing on one the major sub-segments, an overview of the probiotic market in India has been included. This segment has been highlighted owing to the fact that it is one of the most promising categories under the nutraceutical market and has huge growth potential in the near future with growing interests of players. The genesis of probiotics has been highlighted showing the types dominant in India and the key therapeutic benefits derived from them. This section also contains information regarding the market size and growth of probiotics in functional foods in India as well as the key segments and the active players in this space.
This is followed by an analysis of the drivers leading to growth in the market. This includes increasing shift towards preventive therapies, increasing disposable income, increase in healthcare spending, increasing shift towards self-medication, changing demographics, growth in pharmacy and wellness related retail chains and favorable pricing environment. The key challenges to the market include lack of standardization, marketing and distribution challenges, high pricing and lack of awareness. Several trends have also been identified in the market and this has been provided in the next section. The key trends include fortified foods, ayurvedic nutraceuticals, foreign tie-ups, players educating consumers, encapsulation, and cosmeceuticals and nanoceuticals. A section on government regulations in the industry has also been included. It discusses the Food Safety and Standards Act 2006 that regulates the industry.
The competition section provides an overview of the competitive landscape in the industry and
Rise of Retail Chemist Power in India - MedicinMan Anup Soans
With increasing push towards generics being mandated by government of India and Medical Council of India and Civil Society, Will the Retail Chemist emerge stronger in his bargaining power?
PCD PHARMA FRANCHISE COMPANY - AROGYA FORMULATIONS PVT LTD..pptxArogya Formulations
Arogya Formulations is a leading PCD Pharma Franchise Company that specializes in offering a wide range of high-quality pharmaceutical products. With a commitment to health and wellness, the company provides excellent opportunities for individuals and businesses to join their PCD (Propaganda Cum Distribution) Pharma franchise network. Arogya Formulations focuses on delivering innovative and affordable healthcare solutions, ensuring the availability of top-notch pharmaceutical products across various therapeutic segments. The company's dedication to quality, integrity, and customer satisfaction makes it a trusted partner for those seeking to establish a successful presence in the pharmaceutical industry through franchise opportunities.
Visit us at: https://arogyaformulations.com/pcd-pharma-franchise-company/
This presentation by Pradeep Mehta was made at the 2014 Global Forum on Competition (27-28 February) during the session on competition issues in the distribution of pharmaceuticals. Find out more at http://www.oecd.org/competition/globalforum
To date, the Indian pharma market has been dominated by the trade/retail segment. This is unlike most mature
markets globally which usually operate in a multi-channeled business model involving
not only trade outlets, but also hospitals, over-the-counter and retail chains. However, in light of the increasing demand for quality care in hospitals, as well as
increased government spending and recent regulatory changes, India is slowly evolving
into a multi-channel market. The most striking aspect of this shifting paradigm is the
increasing dominance of the hospital segment.
Global interventional cardiology market 2017-2022 sample reportNetscribes, Inc.
Interventional cardiology is the catheter-based treatment of cardiovascular diseases. Certified cardiologists who perform these procedures are known as intervention cardiologists.
https://www.researchonglobalmarkets.com/global-interventional-cardiology-market-2014-2022.html
For the full report please write to info@netscribes.com
The global Telehealth market is estimated to be valued at USD 25.30 billion in 2022, growing at a CAGR of 14% during 2014-2022.
https://www.researchonglobalmarkets.com/global-telehealth-market-2014-2022.html
For the full report please write to info@netscribes.com
Global Telematics Market 2017 - 2022 - Sample PagesNetscribes, Inc.
The global Telematics market is expected to grow at a CAGR of 28.5% (2017-2022) leading to global revenue of USD 233.24 billion by 2022.
https://www.researchonglobalmarkets.com/global-telematics-market-2014-2022.html
For the full report please write to info@netscribes.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. Executive Summary
The market is valued at INR XX bn in 20--; Estimated to reach INR YY bn in 20- -
Market The market is fragmented and dominated by the unorganized sector
There are U pharmacies in India with about V distributors
LE
Drivers: Challenges:
– Increase in healthcare spending – Fragmented industry
Drivers &
Challenges
–
–
MP
Growth in pharmaceuticals sector
Changing disease profile
–
–
Long distribution and supply chain
Counterfeit drugs
A
– Consumer attitudes – FDI regulations
S
– Attractive margins
– Growth in OTC Segment
Loyalty Schemes
Value Added Services
Trends Tie-ups with Retail firms
Rural Expansion
Entry of Government in Pharmacy Retailing
Entry of Private Labels
Organized Retailers starting Pharmacy Chains
Company 1 leads in the organized pharma retail market with highest number of outlets
Competition Leading organized players include Company 1, Company 2, Company 3 and Company 4
Primarily organized retail chains operate either as a company owned or as a franchisee outlet
PHARMACY RETAIL MARKET – INDIA.PPT 2
4. The market is highly fragmented and dominated by the
unorganized sector
Market Overview Overall Market Size & Growth
•There are U pharmacies in India today, with
about V distributors INR bn
LE
•Market is fragmented and dominated by the 600
a% Y
unorganized sector
P
400
•Growth in this market is driven by increasing X
M
200
healthcare spending, growth in organized
retailing and attractive margins
SA
•The entry of organized players is changing the
face of the pharmacy business in India
The organized space of pharmacy retailing is
0
2009 2011
Revenue split – Organized vs Unorganized
Organized
dominated by p-q big players
v%
Primarily, organized retail chains operate either as
a company owned or managed stores or as a
franchisee outlet
•In India, pharmacies/drug stores are the
dominant distribution channel generating b% u%
of the overall pharmaceutical sales Unorganized
Source:
PHARMACY RETAIL MARKET – INDIA.PPT 4
5. Pharmacy chains are expanding operations using various
store formats
Store Format Description
• They are housed in hospitals & dispense a limited number of medicines
Hospital Pharmacies • They cater mainly to the requirements of patients admitted in hospitals
• Stores are located near the residential areas
Standalone Stores • Some of these stores offer home delivery
• The target customers are middle and upper class households
• These are located in supermarkets, malls or departmental stores
Malls/Shop-in-Shops • Company 1has a tie-up with Company 2 for its daily stores in South India
• Pharmacy chains are planning to set up shop in townships
Townships • Company 3 has signed an agreement with Company 4 to set up a
medicity inside the upcoming project T near Pune
Source:
PHARMACY RETAIL MARKET – INDIA.PPT 5
6. Drivers & Challenges
Drivers Challenges
Growth in pharmaceuticals sector Fragmented industry
Increase in healthcare spending Long distribution and supply chain
Changing disease profile Counterfeit drugs
Growth in OTC segment FDI regulations
Attractive margins
Consumer attitude
PHARMACY RETAIL MARKET – INDIA.PPT 6
7. Trends
Loyalty Schemes
Value Added Services
Tie-ups with Retail firms
Trends ` Rural Expansion
Entry of Government in Pharmacy Retailing
Entry of Private Labels
Organized Retailers Starting Pharmacy Chains
PHARMACY RETAIL MARKET – INDIA.PPT 7
8. Company 1 leads the overall market
Competition Overview Organized Pharmacy Distribution
• Company 1 leads in the organized pharma retail
market with highest number of outlets Company 1 740
• Sector has witnessed the entry of new players
LE
Company 2 600
• Almost all players have expansion plans Company 3 350
P
• Organized pharma retail chains operate in three Company 4 130
models: Company 5 112
Fully owned stores
– Company 1 prefers fully owned model
Franchise model
– Company 2 operates in this model SAM Company 6
Company 7
Company 8
Company 9 35
110
92
50
Company 10 30
Combination of owned and franchise stores
– Company 3 prefers a combinational model Company 11 25
Company 12 14
• Franchisee model has enabled loss making stand-
Company 13 12
alone stores to be absorbed by organized retailers
Company 14 10
This is likely to trigger consolidation in this sector
Company 15 6
• Retail outlets of players like Company 4 sell only its
Company 16 6
products No. of Stores
• Leading players are targeting rural areas and are 0 200 400 600 800
tying-up with organized retail players for expansion
Source:
PHARMACY RETAIL MARKET – INDIA.PPT 8
9. Thank you for the attention
The Pharmacy Retail report is part of Research on India’s Healthcare Industry series.
For more detailed information or customized research requirements please contact:
Gagan Uppal Gaurav Kumar
Phone: +91 22 4098 7530 Phone: +91 33 4064 6214
E-Mail: gagan.uppal@netscribes.com E-Mail: gaurav.kumar@netscribes.com
Research on India is a product of Netscribes (India) Pvt. Ltd. Research on India is dedicated to disseminating information and providing quick
insights on “hot” industries in India and other emerging markets. Track our new releases and major updates in these industries on
About Netscribes
Netscribes is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &
business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true
value proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients’ profitability and growth
objectives.
Disclaimer: This report is published for general information only. Although high standards have been used the preparation, Research on India,
Netscribes (India) Pvt. Ltd. or “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the
sole property of Netscribes (India) Pvt. Ltd. and prior permission is required for guidelines on reproduction.
PHARMACY RETAIL MARKET – INDIA.PPT 9